Oral cannabis products are widely used for recreational and therapeutic purposes under varying state-specific regulations. Marijuana products often are standardized in relation to psychoactive tetrahydrocannabinol (THC) or non-psychoactive cannabidiol (CBD) content. Both of these primary cannabinoid constituents have the potential to precipitate interactions with conventional medications.